Skip to content
RushPR News – Lifestyle
Author:
Astrosalva Therapeutics, Inc.
Astrosalva Therapeutics Adds Alexander Disease Scientist Natasha Snider, PhD, to Scientific Advisory Board
November 19, 2026
Astrosalva Therapeutics Adds Michael MacLean, Former CFO of Novartis-Acquired Avidity Biosciences, to Strategic Advisory Board
November 12, 2026
Astrosalva Therapeutics Adds Rare Disease Patient Advocacy Leader Wendy Erler to Strategic Advisory Board
November 5, 2026
A Father’s Search for Answers Leads to Astrosalva Therapeutics, a New Biotech for Alexander Disease and cALD
October 29, 2026